News Feed Opinion Blog Career Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
November, 2024
November 2024
M T W T F S S
 123
45678910
11121314151617
18192021222324
252627282930  
Tuomas Tammela: Co-targeting classical cells and KRAS augments response in pancreas cancer
Photo of Tuomas Tammela from X
Jul 10, 2024, 07:19

Tuomas Tammela: Co-targeting classical cells and KRAS augments response in pancreas cancer

Tuomas Tammela, Associate Member at Memorial Sloan Kettering Cancer Center, shared on X:

“New Paper! Anupriya Singh and Hannah Styers from the lab find acute resistance to targeting KRAS in pancreas cancer is surprisingly driven by a classical epithelial state.

Co-targeting classical cells and KRAS augments response – clinically important!”

Source: Tuomas Tammela/X

A classical epithelial state drives acute resistance to KRAS inhibition in pancreas

Authors: Anupriya Singhal, Hannah C. Styers, Jonathan Rub, Zhuxuan Li, Stefan R. Torborg, Jung Yun Kim, Olivera Grbovic-Huezo, Huijin Feng, Zeynep Cagla. Tarcan, Hulya Sahin Ozkan, Jill Hallin, Olca Basturk, Rona Yaeger, James G. Christensen, Doron Betel, Yan Yan, Iok In Christine Chio, Elisa de Stanchina, Tuomas Tammela

Tuomas Tammela

Anupriya Singh Anupriya Singhal cancer Doron Betel Elisa de Stanchina Hannah C. Styers Hannah Styers Huijin Feng Hulya Sahin Ozkan Iok In Christine Chio James G. Christensen Jill Hallin Jonathan Rub Jung Yun Kim KRAS Memorial Sloan Kettering Cancer Center Olca Basturk Olivera Grbovic-Huezo OncoDaily Oncology Rona Yaeger Stefan R. Torborg Tuomas Tammela Yan Yan Zeynep Cagla. Tarcan Zhuxuan Li
Special Coverage
Insight
Nov 22, 2024, 22:09
5 papers about Lung Cancer suggested by Stephen Liu
Blog
Nov 22, 2024, 21:56
James P. Crowley: How immune system fights cancer and how tumors evade attack
Blog
Nov 22, 2024, 21:43
Miriam Mutebi: Did you know that, on average, your left breast is larger than your right?
Blog
Nov 22, 2024, 21:38
Erman Aytac: Confer 2024 - one of the largest and most prestigious cancer meeting of Romania
Blog
Nov 22, 2024, 21:35
Axel S. Merseburger: Post hoc analysis of TITAN
Blog
Nov 22, 2024, 21:32
Zainab Shinkafi-Bagudu: Courtesy call to the Cuban Ambassador to Nigeria Miriam Morales Palmero
Drugs
Nov 22, 2024, 21:11
Yakup Ergün: Drugs with high and moderate emetogenic potential
Insight
Nov 22, 2024, 21:07
Updates from CTOS with Thierry Alcindor
Insight
Nov 22, 2024, 20:53
Andrea Romanos-Nanclares: Dietary pattern contributing to inflammation is associated with higher breast cancer risk
Insight
Nov 22, 2024, 20:44
Raffaella Casolino: An important milestone in the WHO’s Genomics Programme
Blog
Nov 22, 2024, 20:32
Interact Europe 100 is inspiring cancer centres and Young Cancer Professionals across Europe - ECO
Blog
Nov 22, 2024, 20:24
Belt and Road Office Talk: Enhancing Support for International Students in Hong Kong - The Babak Lab